Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
09/2003
09/04/2003WO2003072559A1 Method for producing 3-amidinophenylalanine derivatives
09/04/2003WO2003072537A2 Selective protein tyrosine phosphatatase inhibitors
09/04/2003WO2003072535A2 Substituted hydroxyethylamines
09/04/2003WO2003072532A1 Ester compound and medicinal use thereof
09/04/2003WO2002068387A8 Acylated piperidine derivatives as melanocortin-4 receptor agonists
09/04/2003US20030166939 Free radical catalysts for unsaturated polymers
09/04/2003US20030166925 4-Substituted piperidine compound
09/04/2003US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
09/04/2003US20030166694 Glycinamides
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166683 N-(4-carbamimidoyl-phenyl)-glycine derivatives
09/04/2003US20030166682 Comprising reacting 4-(4-Hydroxy-1-butynyl)-alpha, alpha-dimethylbenzeneacetic acid methyl ester with a copper and/or silver compound in the presence of palladium or a compound thereof
09/04/2003US20030166668 Substituted heteroarylalkanoic acids
09/04/2003US20030166652 Chemical compounds
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166629 Cyclic quaternary ammonium compounds
09/04/2003US20030166619 N2O2- functionality is bound direct to a carbon atom; treating biological disorders hypertension, restenosis, impotency, genetic disorders or infections
09/04/2003US20030166590 Microsomal triglyceride transfer protein
09/04/2003CA2477607A1 Substituted hydroxyethylamines
09/03/2003EP1340744A2 Hiv protease inhibitors
09/03/2003EP1340499A1 Nootropic effect enhancer
09/03/2003EP1339864A2 Process for the production of piperidine derivatives with microorganisms
09/03/2003EP1339686A2 Cyanoguanidine prodrugs
09/03/2003EP1339685A2 Biphenylcarboxamides useful as lipid lowering agents
09/03/2003EP1339684A1 Mch antagonists and their use in the treatment of obesity
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003EP1339662A1 Novel estrogen receptor ligands and methods iii
09/03/2003EP1060178B1 Heterocyclic compounds as inhibitors of rotamase enzymes
09/03/2003EP0977733B1 Arylsulfonylamino hydroxamic acid derivatives
09/03/2003EP0934271B1 Substituted arylalkylamines as neurokinin antagonists
09/03/2003EP0868182B1 Process for production of piperidine derivatives
09/03/2003CN1440402A N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
09/03/2003CN1440395A COLCHINOL derivatives as vascular damaging agents
09/03/2003CN1440390A Substituted diamide derivatives useful as motilin antagonists
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
09/03/2003CN1120167C Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles having an affinity for alpha and/or 5HTIA receptors
09/03/2003CN1120154C 4-hydroxy-piperdine derivatives
09/02/2003US6613942 Glucagon antagonists/inverse agonists
09/02/2003US6613907 Process for the production of piperidine derivatives with microorganisms
09/02/2003US6613906 Crystal modification
09/02/2003US6613905 Chemokine receptor antagonists and methods of use therefor
09/02/2003US6613803 Treating, preventing or ameliorating pain
09/02/2003US6613795 Respiratory system disorders; muscle relaxants
09/02/2003US6613791 N-substituted azaheterocyclic carboxylic acids and their use
09/02/2003US6613779 Use of R(+) -α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piper idinemethanol for the treatment of sleep disorders
09/02/2003US6613769 Tryptase inhibitors
09/02/2003US6613765 Use of NK-1 receptor antagonists for treating major depressive disorders
09/02/2003US6613764 Aspartic protease inhibitors
09/02/2003US6613572 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
08/2003
08/28/2003WO2003070675A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
08/28/2003WO2003070243A1 Di-ester derivatives as short acting neuromuscular blockers
08/28/2003WO2003070242A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003WO2003017998B1 Platinum complexes and their use in cancer treatment
08/28/2003US20030162966 Reacting an amino alcohol derivative with a sulfonyl halide in a mixed solvent composed of an aprotic organic solvent and water in the presence of a non- water-prohibiting inorganic base to produce sulfonic acid ester derivative
08/28/2003US20030162867 Stabilizer mixtures
08/28/2003US20030162814 Amines such as 2-(3-(N-hydroxyamidino)phenylamino)-N-(2'-sulfamoylbiphenyl-4-yl)-2 -methylpropionamide, used as anticoagulants or for prophylaxis of arteriosclerosis, angina pectoris, restinosis or metastasis
08/28/2003US20030162811 Heterocyclic amines such as 4-(3'-Thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
08/28/2003US20030162787 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
08/28/2003US20030162780 Administering to a patient with a disease treatable with a muscarinic receptor antagonist a 1,2,3,4-tetrahydro-naphthalene-2-yl-alkylaminoalkyl-piperidine derivative
08/28/2003US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
08/28/2003US20030162772 For example, N-(2-(3-((1-(3,4-dichlorobenzylpiperidinyl) aminohydroxypropoxy)phenyl)acetamide; use as modulators of chemokine receptor activity, and may be used in treatment of autoimmune, inflammatory, proliferative diseases
08/28/2003CA2473089A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/27/2003EP1337580A2 Polymeric articles containing hindered amine light stabilizers based on multi-functional carbonyl compounds
08/27/2003EP1337512A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
08/27/2003EP1337251A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
08/27/2003EP1073672B1 Antipicornaviral compounds, their preparation and use
08/27/2003EP0981515B1 Piperidine derivatives as neurotransmitter re-uptake inhibitors
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/27/2003EP0815084B1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
08/27/2003EP0788481B1 Process for preparing levobupivacaine and analogues thereof
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1438999A Serine protease inhibitors
08/27/2003CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
08/27/2003CN1438220A 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative
08/27/2003CN1119336C Novel compounds with analgesic effect
08/27/2003CN1119330C Process and diastereomeric salts usefur for the optical resolution of racemic piperidinebutanol and its derivatives
08/27/2003CN1119322C Process for alkylation of alkyl-or benzylcyanogen derivatives in presence of trialkylamines or-phosphines
08/26/2003US6610851 1-tert-butoxycarbonyl-4-(4-fluorophenyl)-3-((3,4-methylene dioxyphenyl)oxymethyl)piperidine; reacting 4-(4-fluorophenyl)-3-hydroxymethylpiperidine with di-tert-butyl dicarbonate to form the carbamate; 3,4-methylenedioxyphenol
08/26/2003US6610850 Contrast media for angiography
08/26/2003US6610731 Antiinflammatory
08/26/2003US6610717 Selectively inhibits action of N-type calcium channel; treatment of ischemic cerebrovascular disorders caused by cerebral infarction or intracerebral bleeding, Alzheimer's disease, AIDS related dementia, Parkinson's disease
08/26/2003US6610713 Treating cell with cholinergic agonist
08/26/2003US6610711 4-phenylpiperidines for the treatment of pruritic dermatoses
08/26/2003US6610710 Inflammatory bowel diseases, diabetes, tumor proliferation and tumor metastasis.
08/26/2003US6610709 2-n-substituted or unsubstituted-2-amino-5-methylpiperidine-3,4-diols and processes for the preparation thereof
08/26/2003US6610708 Cyclic amino compounds
08/26/2003US6610707 Heterocyclic compounds as inhibitors of rotomase enzymes
08/26/2003US6610705 Process for the preparation of diaryl naphthyl methanes
08/26/2003US6610703 Administering long-chain N-alkyl derivative of deoxynojirimycin having from nine to about twenty carbon atoms in alkyl chain
08/26/2003US6610702 Ammonium salts of inositol hexaphosphate, and uses thereof
08/26/2003US6610284 Preparation for prevention and healing of inflammation affections
08/26/2003CA2243534C Process for the preparation of d-threo-(r,r)-methylphenidate and recycling of undesired enantiomers by epimerisation
08/21/2003WO2003068743A1 Chemical compounds
08/21/2003WO2003068242A1 Phospholipids as caspase inhibitor prodrugs
08/21/2003WO2003067987A1 Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol and their use as pesticide
08/21/2003WO2003018549A3 Bicyclic compounds as inhibitors of chemokine binding to us28
08/21/2003WO2003007930A3 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
08/21/2003WO2002046158A3 Piperidine/piperazine-type inhibitors of p38 kinase
08/21/2003WO2002002512A3 Compounds to treat alzheimer's disease